News
Peter Berezin of BCA Research offers the lowest S&P 500 year-end target at 5,300, with a cautious yet data-driven approach.
Stocks turned in a lackluster performance Friday as Wall Street took a breather at the end of the first week of ...
US stocks were little changed on Friday as the market largely shrugged off tariff tensions amid fresh data that signaled the ...
Sen. Elizabeth Warren sent letters Thursday to agencies including S&P Global Ratings, Moody's Ratings and Fitch Ratings, asking for information about how they score the riskiness of private-credit ...
Lundin Mining expects provisional pricing adjustments and certain non-cash items will hurt its second-quarter results. The mining company said Thursday it expects revenue to be negatively impacted by ...
Sen. Elizabeth Warren sent letters Thursday to agencies including S&P Global Ratings, Moody's Ratings and Fitch Ratings, asking for information about how they score the riskiness of private-credit ...
3d
Investor's Business Daily on MSNStock Market Today: Dow Rises As Fed Officials Are Firm On Rates; Nvidia Scores Record High (Live Coverage)The Dow Jones index rose Thursday on surprise jobless claims and retail sales. Nvidia chipmaker TSMC rose on earnings.
Wall Street is hanging near its records following some better-than-expected updates on the economy and a mixed set of profit reports from big U.S. companies. The S&P 500 was up 0.1% in early trading ...
President Donald Trump sent the U.S. stock market on a jagged round trip after saying he had “talked about the concept of ...
3d
Investor's Business Daily on MSNDow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston ScientificJohnson & JohnsonJNJ stock jumped Wednesday after the Dow Jones health behemoth raised its 2025 guidance in the wake of a bullish second-quarter report.For the year, J&J now expects adjusted earnings ...
Stocks were taken on a wild ride Wednesday as a White House official indicated to CNBC that Trump was moving closer to firing ...
Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results